Blocking a molecule that draws sensory nerves into musculoskeletal injuries prevents heterotopic ossification (HO), a process in which bone abnormally grows in soft tissue during healing, researchers reported. The findings suggest that drugs currently being tested in clinical trials to inhibit this molecule for pain relief could also protect against this challenging condition.
